Kelly A. Gebo

18.9k total citations
185 papers, 7.8k citations indexed

About

Kelly A. Gebo is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Kelly A. Gebo has authored 185 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Infectious Diseases, 96 papers in Epidemiology and 50 papers in Emergency Medicine. Recurrent topics in Kelly A. Gebo's work include HIV/AIDS Research and Interventions (114 papers), HIV-related health complications and treatments (50 papers) and HIV/AIDS drug development and treatment (49 papers). Kelly A. Gebo is often cited by papers focused on HIV/AIDS Research and Interventions (114 papers), HIV-related health complications and treatments (50 papers) and HIV/AIDS drug development and treatment (49 papers). Kelly A. Gebo collaborates with scholars based in United States, Canada and United Kingdom. Kelly A. Gebo's co-authors include Richard D. Moore, John A. Fleishman, P. Todd Korthuis, Baligh R. Yehia, Gregory M. Lucas, Jeanne Keruly, Geetanjali Chander, Richard E. Chaisson, Khalil G. Ghanem and James Hellinger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and The Journal of Experimental Medicine.

In The Last Decade

Kelly A. Gebo

176 papers receiving 7.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly A. Gebo United States 52 5.0k 4.2k 2.0k 1.8k 1.0k 185 7.8k
Marc Bulterys United States 46 4.8k 1.0× 3.5k 0.8× 1.1k 0.6× 2.1k 1.2× 1.2k 1.2× 146 7.0k
Phyllis C. Tien United States 51 3.5k 0.7× 2.3k 0.6× 4.2k 2.1× 1.9k 1.1× 1.1k 1.1× 288 8.2k
Alexandra Calmy Switzerland 53 6.5k 1.3× 3.2k 0.8× 3.3k 1.7× 3.8k 2.1× 517 0.5× 305 10.1k
Sharon Walmsley Canada 47 6.6k 1.3× 4.0k 0.9× 1.9k 1.0× 4.2k 2.3× 502 0.5× 331 10.8k
Kenneth A. Freedberg United States 56 8.1k 1.6× 5.1k 1.2× 1.3k 0.7× 3.3k 1.8× 2.1k 2.1× 271 10.6k
Mary Culnane United States 24 4.5k 0.9× 2.3k 0.6× 1.1k 0.6× 1.9k 1.1× 1.1k 1.0× 38 6.7k
Judith A. Aberg United States 51 5.9k 1.2× 3.0k 0.7× 2.9k 1.5× 2.5k 1.4× 407 0.4× 200 9.2k
Niels Obel Denmark 47 4.3k 0.9× 3.2k 0.8× 2.6k 1.3× 2.3k 1.3× 360 0.4× 317 8.4k
Ruth M. Greenblatt United States 48 3.8k 0.8× 3.1k 0.7× 1.6k 0.8× 2.0k 1.1× 1.2k 1.2× 171 8.7k
Handan Wand Australia 40 2.8k 0.6× 3.1k 0.7× 1.3k 0.6× 1.2k 0.7× 1.5k 1.5× 302 7.8k

Countries citing papers authored by Kelly A. Gebo

Since Specialization
Citations

This map shows the geographic impact of Kelly A. Gebo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly A. Gebo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly A. Gebo more than expected).

Fields of papers citing papers by Kelly A. Gebo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly A. Gebo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly A. Gebo. The network helps show where Kelly A. Gebo may publish in the future.

Co-authorship network of co-authors of Kelly A. Gebo

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly A. Gebo. A scholar is included among the top collaborators of Kelly A. Gebo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly A. Gebo. Kelly A. Gebo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sulaiman, Andrew, Christi E. Marshall, Reinaldo E. Fernández, et al.. (2025). SARS‐CoV‐2 IgG antibodies in COVID‐19 convalescent plasma and conventional plasma units. Transfusion. 65(3). 446–452.
2.
Judson, Seth D., Chloe Orkin, & Kelly A. Gebo. (2025). Mpox: What Have We Learned and How Do We Better Prepare for the Future?. The Journal of Infectious Diseases. 232(2). 270–273. 1 indexed citations
3.
Forster, Ryan, Melissa Schnure, Joyce Jones, et al.. (2025). The Potential Impact of Ending the Ryan White HIV/AIDS Program on HIV Incidence: A Simulation Study in 31 U.S. Cities. Annals of Internal Medicine. 178(11). 1580–1590. 1 indexed citations
4.
Davy-Méndez, Thibaut, Sonia Napravnik, Brenna Hogan, et al.. (2025). Changes in the Prevalence of Non-AIDS Conditions Among Hospitalized Persons With HIV in the United States and Canada, 2008–2018. Clinical Infectious Diseases. 81(4). 806–814.
5.
Bloch, Evan M., David Sullivan, Arturo Casadevall, et al.. (2024). Applying lessons of COVID-19 and other emerging infectious diseases to future outbreaks. mBio. 15(6). e0110924–e0110924. 3 indexed citations
6.
Jones, Joyce, Kelly A. Gebo, Bhakti Hansoti, et al.. (2024). Discordant performance of mpox serological assays. Journal of Virological Methods. 329. 115004–115004. 3 indexed citations
7.
Jones, Joyce, Renata Sanders, Matthew M. Hamill, et al.. (2023). Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients. The Journal of Infectious Diseases. 229(1). 54–58. 8 indexed citations
8.
Chander, Geetanjali, Joyce Jones, Anthony T. Fojo, et al.. (2023). Telemedicine Use Among People With HIV in 2021: The Hybrid-Care Environment. JAIDS Journal of Acquired Immune Deficiency Syndromes. 92(3). 223–230. 7 indexed citations
9.
Bloch, Evan M., Xianming Zhu, Eshan U. Patel, et al.. (2023). Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample. Clinical Infectious Diseases. 77(2). 237–241. 2 indexed citations
10.
Hudgens, Michael G., Haidong Lu, Stephen R. Cole, et al.. (2023). Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine. American Journal of Epidemiology. 192(8). 1341–1349. 1 indexed citations
11.
Bloch, Evan M., David Sullivan, Shmuel Shoham, et al.. (2022). The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox. mBio. 13(6). e0286222–e0286222. 14 indexed citations
12.
Keruly, Jeanne, Joyce Jones, Anthony T. Fojo, et al.. (2022). Time Between Viral Loads for People With HIV During the COVID-19 Pandemic. JAIDS Journal of Acquired Immune Deficiency Syndromes. 91(1). 109–116. 5 indexed citations
13.
Lesko, Catherine R., et al.. (2021). Visit completion during the telemedicine transition in early months of the pandemic. 29(1). 286–287. 4 indexed citations
14.
DiBiase, Rebecca, Mary Catherine Beach, Joseph A. Carrese, et al.. (2020). A medical student scholarly concentrations program: scholarly self-efficacy and impact on future research activities. Medical Education Online. 25(1). 1786210–1786210. 13 indexed citations
15.
Holko, Michelle, Francis Ratsimbazafy, Karthik Natarajan, et al.. (2020). Fitbit "Bring Your Own Device" data in the All of Us Research Program.. AMIA. 2 indexed citations
16.
Berry, Stephen A., Khalil G. Ghanem, William C. Mathews, et al.. (2015). Brief Report. JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(3). 275–279. 11 indexed citations
17.
Schackman, Bruce R., John A. Fleishman, Amanda Su, et al.. (2015). The Lifetime Medical Cost Savings From Preventing HIV in the United States. Medical Care. 53(4). 293–301. 84 indexed citations
18.
Berry, Stephen A., John A. Fleishman, Baligh R. Yehia, et al.. (2013). Thirty-day hospital readmission rate among adults living with HIV. AIDS. 27(13). 2059–2068. 27 indexed citations
19.
Losina, Elena, Bruce R. Schackman, Kelly A. Gebo, et al.. (2009). Racial and Sex Disparities in Life Expectancy Losses among HIV‐Infected Persons in the United States: Impact of Risk Behavior, Late Initiation, and Early Discontinuation of Antiretroviral Therapy. Clinical Infectious Diseases. 49(10). 1570–1578. 139 indexed citations
20.
Rutstein, Richard M., Kelly A. Gebo, George K. Siberry, et al.. (2005). Hospital and Outpatient Health Services Utilization Among HIV-Infected Children in Care 2000–2001. Medical Care. 43(9). III–31. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Bulterys Breakdown of academic impact, for papers by Phyllis C. Tien Breakdown of academic impact, for papers by Alexandra Calmy Breakdown of academic impact, for papers by Sharon Walmsley Breakdown of academic impact, for papers by Kenneth A. Freedberg Breakdown of academic impact, for papers by Mary Culnane Breakdown of academic impact, for papers by Judith A. Aberg Breakdown of academic impact, for papers by Niels Obel Breakdown of academic impact, for papers by Ruth M. Greenblatt Breakdown of academic impact, for papers by Handan Wand
Rankless by CCL
2026